Goldman Sachs’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
Other funds holding VSTM
RI
DTC
AC
NCM
VCM
SCM
FCMV
Goldman Sachs's VSTM Position: Q1 2026 in Review
Goldman Sachs reduced its Verastem (VSTM) stake by 0.76% in Q1 2026, selling an estimated $70.4K and leaving 1,484,003 shares worth $7.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3267.
Goldman Sachs first reported a position in VSTM in Q2 2013 and has held it in 45 quarters since. The position peaked at $11.5M in Q4 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.
- Goldman Sachs held 1,484,003 shares of Verastem worth $7.87M as of Q1 2026.
- Goldman Sachs sold 11,421 Verastem shares in Q1 2026, an estimated $70.4K.
- Verastem made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3267 holding.
- Goldman Sachs first reported a position in Verastem in Q2 2013 and has held it in 45 quarters since.
- Goldman Sachs's Verastem position peaked at $11.5M in Q4 2025.
- 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.